You just read:

Kowa Achieves Goal Of Randomizing 10,000 Patients Into Landmark "PROMINENT" Cardiovascular Outcomes Study Of K-877 (Pemafibrate)

News provided by

Kowa Research Institute, Inc.

Feb 19, 2020, 09:00 ET